RoboCT

Market context

RoboCT represents part of China's growing rehabilitation robotics sector, with assistive exoskeleton systems already deployed in clinical environments. The company combines medical robotics deployment with in-house actuator and joint module development, positioning it within the assistive mobility robotics ecosystem.

Products

• UGO

Facts

• Website: https://en.roboct.com
• HQ: Hangzhou, China
• Founded: 2017
• Segment: Healthcare
• Known funding rounds: 1

Funding

• 2026-03-05 - Series B+ - $13.7M - RoboCT Raises $13.7 Million in Series B+ Funding Round - source: example.com

Investors

• ABC Capital - Lead - Vc - 1 funding event - first seen 2026-03-05
• XYZ Capital - Lead - Vc - 1 funding event - first seen 2026-03-05

Exoskeleton rehabilitation robot company

RoboCT develops exoskeleton robotics products and rehabilitation solutions for medical institutions and individual users.

• Target environment: Hospitals, rehabilitation clinics, home rehabilitation settings, care environments and lower-limb mobility support.
• Deployment model: Medical exoskeleton products, rehabilitation cloud services and customized solutions for clinical and individual users.
• Customer context: Medical institutions, rehabilitation providers, patients with motor impairments and care teams.
• Workflow context: Gait training, lower-limb rehabilitation, mobility assistance, rehabilitation monitoring and therapy support.
• Commercial maturity: Commercial rehabilitation robotics company with product families for medical, household and component use.
• Market position: Healthcare robotics company focused on exoskeleton-assisted rehabilitation and mobility support.
• Adoption constraints: Adoption depends on clinical outcomes, reimbursement, therapist workflow fit, patient eligibility, safety, cost and support coverage.
• Adjacent context: Adjacent context includes rehabilitation exoskeletons, gait training robots, home assistive devices and clinical mobility robotics.
• Source confidence: high

Events

• 2026-03-05 - Funding - RoboCT Raises $13.7 Million in Series B+ Funding Round - • RoboCT secured $13.7 million in a Series B+ funding round. • The investment was led by XYZ Capital, with participation from ABC Ventures and DEF Partners. • The funds will be used to expand production capabilities and enhance research and development effort…

Team

• Wang Tian - Founder and CEO - Wang leads RoboCT's exoskeleton robotics and embodied-intelligence work.

Context tags

• Wearable rehab robot OEM - Stack Layer - RoboCT builds complete wearable rehab exoskeleton systems.
• Rehab exoskeleton builder - Peer Group - RoboCT builds rehabilitation exoskeletons for medical therapy.
• Medical exoskeletons - Peer Group - RoboCT exoskeletons serve medical rehabilitation applications.
• Gait rehabilitation - Workflow - RoboCT UGO supports lower-limb walking rehabilitation.
• Powered limb assistance - Capability - RoboCT provides powered limb assistance for rehab therapy.
• Rehabilitation robotics - Peer Group - RoboCT develops robotic rehabilitation systems.
• Rehabilitation robotics platform - Stack Layer - RoboCT provides rehabilitation robotics platforms.
• Intent-based motion control - Capability - RoboCT uses motion intent detection for exoskeleton control.
• Commercial deployment - Commercial Stage - RoboCT has commercial rehab exoskeleton deployments.
• Home assistive care - Customer Environment - RoboCT supports home and community assistive care use.
• Rehabilitation clinics - Customer Environment - RoboCT exoskeletons are used in rehabilitation clinics.